{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T06:36:29Z","timestamp":1719038189245},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,7,10]],"date-time":"2015-07-10T00:00:00Z","timestamp":1436486400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s11255-015-1015-z","type":"journal-article","created":{"date-parts":[[2015,7,9]],"date-time":"2015-07-09T11:34:18Z","timestamp":1436441658000},"page":"1423-1428","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The use of mycophenolate mofetil in experimental encapsulating peritoneal sclerosis"],"prefix":"10.1007","volume":"47","author":[{"given":"B\u00fclent","family":"Huddam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"Ba\u015faran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fclay","family":"Ko\u00e7ak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alper","family":"Azak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Funda","family":"Yal\u00e7\u0131n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nihan Haberal","family":"Reyhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"Duranay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,10]]},"reference":[{"key":"1015_CR1","first-page":"6","volume":"27","author":"M Ertilav","year":"2011","unstructured":"Ertilav M, Timur O, H\u00fcr E, Bozkurt D, Nar H, Kologlu T, Sen S, Duman S (2011) What does the dialysate level of matrix metalloproteinase 2 tell us? Adv Perit Dial 27:6\u201310","journal-title":"Adv Perit Dial"},{"issue":"suppl 2","key":"1015_CR2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/089686080702702s06","volume":"27","author":"RT Krediet","year":"2007","unstructured":"Krediet RT (2007) 30\u00a0years of peritoneal dialysis development: the past and the future. Perit Dial Int 27(suppl 2):35\u201341","journal-title":"Perit Dial Int"},{"key":"1015_CR3","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/ndt\/gfl566","volume":"22","author":"I Hirahara","year":"2007","unstructured":"Hirahara I, Inoue M, Okuda K, Ando Y, Muto S, Kusano E (2007) The potential of matrix metalloproteinase\u20132 as a marker of peritoneal injury increased solute transport, or progression to encapsulating peritoneal sclerosis during peritoneal dialysis\u2013a multicentre study in Japan. Nephrol Dial Transplant 22:560\u2013567","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 4","key":"1015_CR4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/089686080502504S05","volume":"25","author":"H Nakamoto","year":"2005","unstructured":"Nakamoto H (2005) Encapsulating peritoneal sclerosis\u2013a clinician\u2019s approach to diagnosis and medical treatment. Perit Dial Int 25(Suppl 4):30\u201338","journal-title":"Perit Dial Int"},{"key":"1015_CR5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/089686080502500312","volume":"25","author":"CF Wong","year":"2005","unstructured":"Wong CF, Beshir S, Khalil A, Pai P, Ahmad R (2005) Successful treatment of encapsulating peritoneal sclerosis with azathioprine and prednisolone. Perit Dial Int 25:285\u2013287","journal-title":"Perit Dial Int"},{"key":"1015_CR6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1053\/j.ajkd.2007.07.036","volume":"51","author":"JP Lafrance","year":"2008","unstructured":"Lafrance JP, L\u00e9tourneau I, Ouimet D, Bonnardeaux A, Leblanc M, Mathieu N, Pichette V (2008) Successful treatment of encapsulating peritoneal sclerosis with immunosuppressive therapy. Am J Kidney Dis 51:7\u201310","journal-title":"Am J Kidney Dis"},{"key":"1015_CR7","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1177\/089686080702700603","volume":"27","author":"MW Fieren","year":"2007","unstructured":"Fieren MW, Betjes MG, Korte MR, Boer WH (2007) Posttransplant encapsulating peritoneal sclerosis: a worrying new trend? Perit Dial Int 27:619\u2013624","journal-title":"Perit Dial Int"},{"issue":"1\u20133","key":"1015_CR8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejphar.2012.05.001","volume":"688","author":"S Jiang","year":"2012","unstructured":"Jiang S, Tang Q, Rong R, Tang L, Xu M, Lu J, Jia Y, Ooi Y, Hou J, Guo J, Yang B, Zhu T (2012) Mycophenolate mofetil inhibits macrophage infiltration and kidney fibrosis in long-term ischemia-reperfusion injury. Eur J Pharmacol 688(1\u20133):56\u201361","journal-title":"Eur J Pharmacol"},{"key":"1015_CR9","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/ndt\/16.6.1262","volume":"16","author":"Y Ishii","year":"2001","unstructured":"Ishii Y, Sawada T, Shimizu A, Tojimbara T, Nakajima I, Fuchinoue S et al (2001) An experimental sclerosing encapsulating peritonitis model in mice. Nephrol Dial Transplant 16:1262\u20131266","journal-title":"Nephrol Dial Transplant"},{"key":"1015_CR10","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1681\/ASN.V132470","volume":"13","author":"JD Williams","year":"2002","unstructured":"Williams JD, Craig KJ, Topley N, Von Ruhland C, Fallon M, Newman GR et al (2002) Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 13:470\u2013479","journal-title":"J Am Soc Nephrol"},{"key":"1015_CR11","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s11926-010-0116-z","volume":"12","author":"DP Ascherman","year":"2010","unstructured":"Ascherman DP (2010) Interstitial lung disease in rheumatoid arthritis. Curr Rheumatol Rep 12:363\u2013369","journal-title":"Curr Rheumatol Rep"},{"key":"1015_CR12","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1517\/13543781003765461","volume":"19","author":"M Koukoulaki","year":"2010","unstructured":"Koukoulaki M, Goumenos DS (2010) The accumulated experience with the use of mycophenolate mofetil in primary glomerulonephritis. Expert Opin Investig Drugs 19:673\u2013687","journal-title":"Expert Opin Investig Drugs"},{"key":"1015_CR13","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.coph.2013.05.016","volume":"13","author":"M Antic","year":"2013","unstructured":"Antic M, Distler JH, Distler O (2013) Treating skin and lung fibrosis in systemic sclerosis: a future filled with promise? Curr Opin Pharmacol 13:455\u2013462","journal-title":"Curr Opin Pharmacol"},{"key":"1015_CR14","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1124\/jpet.106.117051","volume":"321","author":"N Roos","year":"2007","unstructured":"Roos N, Poulalhon N, Farge D, Madelaine I, Mauviel A, Verrecchia F (2007) In vitro evidence for a direct antifibrotic role of the immunosuppressive drug mycophenolate mofetil. J Pharmacol Exp Ther 321:583\u2013589","journal-title":"J Pharmacol Exp Ther"},{"key":"1015_CR15","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.transproceed.2005.01.049","volume":"37","author":"JR Waller","year":"2005","unstructured":"Waller JR, Brook NR, Bicknell GR, Murphy GJ, Nicholson ML (2005) Mycophenolate mofetil inhibits intimal hyperplasia and attenuates the expression of genes favouring smooth muscle cell proliferation and migration. Transplant Proc 37:164\u2013166","journal-title":"Transplant Proc"},{"key":"1015_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5414\/CN107140","volume":"77","author":"E Hur","year":"2012","unstructured":"Hur E, Bozkurt D, Timur O, Bicak S, Sarsik B, Akcicek F, Duman S (2012) The effects of mycophenolate mofetil on encapsulated peritoneal sclerosis model in rats. Clin Nephrol 77:1\u20137","journal-title":"Clin Nephrol"},{"key":"1015_CR17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10157-004-0328-5","volume":"9","author":"Y Masunaga","year":"2005","unstructured":"Masunaga Y, Hirahara I, Shimano Y, Kurosu M, Iimura O, Miyata Y, Amemiya M, Homma S, Kusano E, Asano Y (2005) A case of encapsulating peritoneal sclerosis at the clinical early stage with high concentration of matrix metalloproteinase-2 in peritoneal effluent. Clin Exp Nephrol 9:85\u201389","journal-title":"Clin Exp Nephrol"},{"key":"1015_CR18","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1093\/ndt\/gfh262","volume":"19","author":"I Hirahara","year":"2004","unstructured":"Hirahara I, Ogawa Y, Kusano E, Asano Y (2004) Activation of matrix metalloproteinase-2 causes peritoneal injury during peritoneal dialysis in rats. Nephrol Dial Transplant 19:1732\u20131741","journal-title":"Nephrol Dial Transplant"},{"key":"1015_CR19","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3747\/pdi.2012.01063","volume":"33","author":"DL Barreto","year":"2013","unstructured":"Barreto DL, Coester AM, Struijk DG, Krediet RT (2013) Can effluent matrix metalloproteinase 2 and plasminogen activator inhibitor 1 be used as biomarkers of peritoneal membrane alterations in peritoneal dialysis patients? Perit Dial Int 33:529\u2013537","journal-title":"Perit Dial Int"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-015-1015-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-015-1015-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-015-1015-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T22:01:16Z","timestamp":1652824876000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-015-1015-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,10]]},"references-count":19,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["1015"],"URL":"https:\/\/doi.org\/10.1007\/s11255-015-1015-z","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,10]]}}}